Ipilimumab and Nivolumab in Leptomeningeal Metastases

Clinical trial NCT02939300 · COMPLETED

Trial details

NCT number: NCT02939300
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leptomeningeal Carcinomatosis

Start date: 2018-02-15
Primary completion: 2021-07-22
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.